Sihuan Pharmaceutical Holdings Group Ltd. (0460.HK)

HKD 0.67

(0.0%)

Total Assets Summary of Sihuan Pharmaceutical Holdings Group Ltd.

Sihuan Pharmaceutical Holdings Group Ltd.'s latest annual total assets in 2023 was 11.53 Billion CNY , down -4.98% from previous year.
Sihuan Pharmaceutical Holdings Group Ltd.'s latest quarterly total assets in 2024 Q2 was 11.52 Billion CNY , down 0.0% from previous quarter.
Sihuan Pharmaceutical Holdings Group Ltd. reported annual total assets of 12.14 Billion CNY in 2022, down -16.25% from previous year.
Sihuan Pharmaceutical Holdings Group Ltd. reported annual total assets of 14.49 Billion CNY in 2021, up 11.13% from previous year.
Sihuan Pharmaceutical Holdings Group Ltd. reported quarterly total assets of 11.53 Billion CNY for 2023 FY, down -4.98% from previous quarter.
Sihuan Pharmaceutical Holdings Group Ltd. reported quarterly total assets of 11.53 Billion CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Sihuan Pharmaceutical Holdings Group Ltd. (2023 - 2006)

Historical Annual Total Assets of Sihuan Pharmaceutical Holdings Group Ltd. (2023 - 2006)

Year	Total Assets	Total Assets Growth
2023	11.53 Billion CNY	-4.98%
2022	12.14 Billion CNY	-16.25%
2021	14.49 Billion CNY	11.13%
2020	13.04 Billion CNY	3.76%
2019	12.57 Billion CNY	-18.6%
2018	15.44 Billion CNY	13.62%
2017	13.59 Billion CNY	11.52%
2016	12.18 Billion CNY	-1.08%
2015	12.32 Billion CNY	8.81%
2014	11.32 Billion CNY	13.1%
2013	10.01 Billion CNY	5.84%
2012	9.45 Billion CNY	6.84%
2011	8.85 Billion CNY	28.27%
2010	6.9 Billion CNY	488.22%
2009	1.17 Billion CNY	36.12%
2008	862.05 Million CNY	36.72%
2007	630.54 Million CNY	218.09%
2006	198.23 Million CNY	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	11.52 Billion CNY	0.0%
2023 FY	11.53 Billion CNY	-4.98%
2023 Q4	11.53 Billion CNY	0.0%
2023 Q2	11.77 Billion CNY	0.0%
2022 FY	12.14 Billion CNY	-16.25%
2022 Q2	14.41 Billion CNY	0.0%
2022 Q4	12.14 Billion CNY	0.0%
2021 FY	14.49 Billion CNY	11.13%
2021 Q2	14.3 Billion CNY	0.0%
2021 Q4	14.49 Billion CNY	0.0%
2020 Q4	13.04 Billion CNY	0.0%
2020 Q2	13.11 Billion CNY	0.0%
2020 FY	13.04 Billion CNY	3.76%
2019 FY	12.57 Billion CNY	-18.6%
2019 Q2	13.76 Billion CNY	0.0%
2019 Q4	12.57 Billion CNY	0.0%
2018 Q4	15.44 Billion CNY	0.0%
2018 Q2	14.69 Billion CNY	0.0%
2018 FY	15.44 Billion CNY	13.62%
2017 Q4	13.59 Billion CNY	0.0%
2017 FY	13.59 Billion CNY	11.52%
2017 Q2	13.49 Billion CNY	0.0%
2016 Q2	13.04 Billion CNY	0.0%
2016 Q4	12.18 Billion CNY	0.0%
2016 FY	12.18 Billion CNY	-1.08%
2015 Q4	12.32 Billion CNY	0.0%
2015 Q2	12.33 Billion CNY	0.0%
2015 FY	12.32 Billion CNY	8.81%
2014 Q2	10.43 Billion CNY	0.0%
2014 Q4	11.32 Billion CNY	0.0%
2014 FY	11.32 Billion CNY	13.1%
2013 Q2	9.39 Billion CNY	0.0%
2013 Q4	10.01 Billion CNY	0.0%
2013 FY	10.01 Billion CNY	5.84%
2012 FY	9.45 Billion CNY	6.84%
2012 Q4	9.45 Billion CNY	0.0%
2012 Q2	8.79 Billion CNY	0.0%
2011 Q4	8.85 Billion CNY	0.0%
2011 FY	8.85 Billion CNY	28.27%
2011 Q2	8.97 Billion CNY	0.0%
2010 FY	6.9 Billion CNY	488.22%
2010 Q4	6.9 Billion CNY	0.0%
2009 FY	1.17 Billion CNY	36.12%
2008 FY	862.05 Million CNY	36.72%
2007 FY	630.54 Million CNY	218.09%
2006 FY	198.23 Million CNY	0.0%

Peer Total Assets Comparison of Sihuan Pharmaceutical Holdings Group Ltd.

Name	Total Assets	Total Assets Difference
Pak Fah Yeow International Limited	907.46 Million HKD	-1171.171%
Grand Pharmaceutical Group Limited	22.51 Billion HKD	48.766%
Extrawell Pharmaceutical Holdings Limited	1.28 Billion HKD	-796.172%
Wai Yuen Tong Medicine Holdings Limited	2.09 Billion HKD	-450.588%
Qianhai Health Holdings Limited	478.11 Million HKD	-2312.679%
Lee's Pharmaceutical Holdings Limited	2.89 Billion HKD	-299.058%
Essex Bio-Technology Limited	2.82 Billion HKD	-307.964%
Tongfang Kontafarma Holdings Limited	1.72 Billion HKD	-567.817%
PuraPharm Corporation Limited	843.96 Million HKD	-1266.817%
SSY Group Limited	11.96 Billion HKD	3.601%
JBM (Healthcare) Limited	1.38 Billion HKD	-730.666%
Jacobson Pharma Corporation Limited	3.48 Billion HKD	-230.826%
China Resources Pharmaceutical Group Limited	271.69 Billion HKD	95.754%